Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLEET-Valley Fever
NCT02663674Phase 4Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2015
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coccidioidomycosis comparing Fluconazole with Placebo (2 arms). Primary endpoint: Proportion of Participants Who Achieve a Clinical Response (50% Reduction in FLEET CAP Score) at Day 22. Started Dec 2015; status: terminated.
02
Drugs
fluconazole
03
Conditions
coccidioidomycosis
Beyond the preview
Go deeper on NCT02663674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663674.